| Name | Walgreens #1852 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1478 Highland Ave, Needham, Massachusetts 02492 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (781) 444-5714 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
The biggest study into the treatment of urinary incontinence with botulinum toxin (trade name Botox) has demonstrated that it is effective in treating overactive bladder (OAB) - a debilitating common condition which can affect up to 20% of people over the age of 40.
The health law is signed - though some changes are still pending - but the fight continues, The Washington Post reports. "Interest groups that spent the past year fighting over President Obama's health-care overhaul are quickly transforming themselves for battle in a new arena, working to sway the law to their benefit while helping the lawmakers who supported them during the bruising legislative debate. For instance, labor unions and industry lobbying groups will attempt to influence regulation writing. Progressives and unions will spend millions to sell the still-controversial plan to voters. Conservatives who opposed it are now retargeting their ire to vulnerable Democratic lawmakers who supported the legislation
New research published in the January 2016 issue of The FASEB Journal suggests that the G-protein-coupled receptor 119 (GPR119) could be a viable treatment target for nonalcoholic fatty liver disease. This receptor has already been identified as a drug target for diabetes and obesity, and this report raises hopes that compounds that target GPR119 for diabetes or obesity might also work for non-alcoholic fatty liver disease.
› Verified 2 days ago
| NPI Number | 1881609071 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #1852 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1478 Highland Ave, Needham, MA 02492 |
| Phone Number | 781-444-5714 |
News Archive
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
The biggest study into the treatment of urinary incontinence with botulinum toxin (trade name Botox) has demonstrated that it is effective in treating overactive bladder (OAB) - a debilitating common condition which can affect up to 20% of people over the age of 40.
The health law is signed - though some changes are still pending - but the fight continues, The Washington Post reports. "Interest groups that spent the past year fighting over President Obama's health-care overhaul are quickly transforming themselves for battle in a new arena, working to sway the law to their benefit while helping the lawmakers who supported them during the bruising legislative debate. For instance, labor unions and industry lobbying groups will attempt to influence regulation writing. Progressives and unions will spend millions to sell the still-controversial plan to voters. Conservatives who opposed it are now retargeting their ire to vulnerable Democratic lawmakers who supported the legislation
New research published in the January 2016 issue of The FASEB Journal suggests that the G-protein-coupled receptor 119 (GPR119) could be a viable treatment target for nonalcoholic fatty liver disease. This receptor has already been identified as a drug target for diabetes and obesity, and this report raises hopes that compounds that target GPR119 for diabetes or obesity might also work for non-alcoholic fatty liver disease.
› Verified 2 days ago
News Archive
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
The biggest study into the treatment of urinary incontinence with botulinum toxin (trade name Botox) has demonstrated that it is effective in treating overactive bladder (OAB) - a debilitating common condition which can affect up to 20% of people over the age of 40.
The health law is signed - though some changes are still pending - but the fight continues, The Washington Post reports. "Interest groups that spent the past year fighting over President Obama's health-care overhaul are quickly transforming themselves for battle in a new arena, working to sway the law to their benefit while helping the lawmakers who supported them during the bruising legislative debate. For instance, labor unions and industry lobbying groups will attempt to influence regulation writing. Progressives and unions will spend millions to sell the still-controversial plan to voters. Conservatives who opposed it are now retargeting their ire to vulnerable Democratic lawmakers who supported the legislation
New research published in the January 2016 issue of The FASEB Journal suggests that the G-protein-coupled receptor 119 (GPR119) could be a viable treatment target for nonalcoholic fatty liver disease. This receptor has already been identified as a drug target for diabetes and obesity, and this report raises hopes that compounds that target GPR119 for diabetes or obesity might also work for non-alcoholic fatty liver disease.
› Verified 2 days ago
Cvs Pharmacy # 02128 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 936 Highland Avenue, Needham, Massachusetts 02494 Phone: (781) 453-0550 | |
Cvs Pharmacy #00674 Type: Medicare Supplier Location: 980-986 Great Plain Ave, Needham, Massachusetts 02492 Phone: (781) 449-2270 | |
Walgreens #1852 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1478 Highland Ave, Needham, Massachusetts 02492 Phone: (781) 444-5714 |